drug delivery - search results

Zhihui Wang and Vittorio Cristini provide evidence that could improve the success of treatment plans and make predicting cancer treatment outcome easier Current processes for creating cancer treatment plans are primarily based on empirical data from clinical trials, consensus expert panel guidelines, and limited laboratory-based testing. Physicians still face major...

Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...

Dr. Siddharth V. Patwardhan, Head of the Green Nanomaterials Research Group at the University of Sheffield highlights nanomaterials and their functions… Nanomaterials are worth multibillions of dollars globally but their production is wasteful and environmentally damaging. At the Green Nanomaterials Research Group, University of Sheffield, we focus on discovery, design...

A new class of nanotherapy blockades the genetic drive for multiple myeloma progression. Gregory M. Lanza and Michael H Tomasson, of Department of Medicine, Washington University School of Medicine explain... Multiple myeloma is malignancy of plasma cells that reside in the bone marrow and normally function as part of our immune defence...

Although a small field in medicine, dermatological diseases are very frequent and span a wide range of illnesses such as allergies, inflammation (e.g. atopic dermatitis, psoriasis), autoimmune diseases or malignancies (e.g. melanoma). Thus, translational dermatological research is an important, innovative field for future basic and clinical research for many...

One of the most remarkable things about life on earth, in all its forms, is how cells often only tens of microns in diameter have evolved to carry out the variety of tasks that they do. In multicellular organisms, the situation is even more complicated, as different cell types...

Vittorio Cristini1,2, Eugene J. Koay3, and Zhihui Wang1,2 1Department of NanoMedicine and Biomedical Engineering, University of Texas Medical School at Houston, Houston, TX 77054, USA 2Brown Foundation Institute of Molecular Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA 3Department of Radiation Oncology, University of Texas MD Anderson Cancer...

E-booklet (Uppsala Universitat - Understanding Brain Drug Delivery - 2014) "I've had the pleasure of working with Adjacent Digital Politics Ltd., where in I was one of the contributors to their monthly edition. A special mention about the top-class material they publish across industry verticals that caters to the interests...

“Central nervous system diseases are on their way to become as abandoned as infectious diseases, in spite of the enormous need for new treatments to reduce the suffering and the huge societal costs handling these diseases.” Appropriate drug delivery to the brain is one of the main hurdles for treating...

Cannabis is the most consumed illicit drug in Europe. Latest estimates from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) indicate that about 23 million (8%) adults (15-64 years old) used cannabis in 2022

Deborah currently works at the Medicines Manufacturing Innovation Centre (MMIC) as a Grand Challenge Lead The role includes defining and managing the overall strategy for the delivery of “Grand Challenge” programmes, within the MMIC business model.  This role is not only technical, but also includes strategic planning, stakeholder management alongside...

We spoke to Dr Charles Shepherd about the impact of myalgic encephalomyelitis/chronic fatigue syndrome and why more needs to be done to address gaps in care and research.

Marc Hoogstad, Head of Product Management at Finworks, explores various ways in which workflow management platforms can enhance collaboration and productivity.

The opioid crisis in Canada has been an issue for nearly a quarter of a century. Here, Norm Buckley and Jason Busse from the Michael G DeGroote Institute for Pain Research and Care, and the National Pain Centre discuss the issue, its effects both general and on specific communities, and what can be done about it.

Alexander Gebauer, the Chief Executive Officer at Secarna Pharmaceuticals GmbH & Co. KG looks at a new approach to solve unmet medical needs with antisense therapies Despite major therapeutic advances, there is a variety of diseases that are still not adequately addressed by traditional approaches such as small molecules or...

The field of restorative justice can be traced to the 1970s and efforts in several North American communities that were applying peacemaking principles – often in tandem with faith-informed perspectives – to the criminal justice system, here we explore it in further detail.

Dr Tracey Pollard from RNID, the charity which supports the 12 million people in the UK who are deaf, have hearing loss or tinnitus, talks us through the causes and impact of hearing loss and how RNID is working to improve research and related treatments in this field.

Metformin offers pregnant women hope as an effective alternative for gestational diabetes treatment and management worldwide Scientists at the University of Galway have made notable progress in treating gestational diabetes mellitus following a clinical study involving pregnant women, offering renewed optimism to pregnant women dealing with this condition. The findings from...

Sustainable medicines maximise benefits for people while minimising harms to the environment and costs, find out more in this eBook.

Telemedicine overcomes the physical limitations of conventional services by utilizing a variety of applications such as telephone, video- conferencing platforms and wearable devices; here we explore the benefits of telemedicine for people with dementia.